The presentation of clinical trial data is a significant event for biotech companies like Invivyd. Positive data can lead to increased investor confidence and a potential rise in stock price, while negative data can have the opposite effect. The announcement of the presentation at a major conference suggests that Invivyd is confident in its results, which could positively influence its stock price.